Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A3 pseudogene 6 (HNRNPA3P6)

Target
HNRNPA3P6
Molecular classification
Pseudogene, Other
01

Overview

HNRNPA3P6 is a human pseudogene derived from the heterogeneous nuclear ribonucleoprotein A3 gene. Pseudogenes like HNRNPA3P6 are defined by their sequence similarities to protein-coding genes but with disabling mutations that prevent protein expression. While some pseudogenes have regulatory roles as non-coding RNAs, direct biological or disease contributions of HNRNPA3P6 have not been established in the published literature. It is not a receptor, enzyme, transporter, transcription factor, nor a canonical therapeutic target. HNRNPA3P6 is catalogued in major genomics databases (NCBI Gene: 653115, HGNC: 48495, Ensembl: ENSG00000213300). No aliases corresponding to drug targets, mechanisms, or disease relevance have been found. Summary of caveats: - This target is not a receptor, not an enzyme, not a transporter, nor a transcription factor. - It is NOT considered a therapeutic or diagnostic drug target. - There is no evidence for specific biological activities, disease roles, interacting drugs, or use as a biomarker for HNRNPA3P6. - Therefore, it should not be used as the basis for therapeutic targeting or biomarker development. If you intended to refer to a functional member of the heterogeneous nuclear ribonucleoprotein A/B family, such as HNRNPA3, please clarify, as those are protein-coding genes with substantial functional and disease relevance.

Other names
HNRNPA3P6Heterogeneous nuclear ribonucleoprotein A3 pseudogene 6NCBI Gene: 653115HGNC: 48495ENSG00000213300
02

Mechanism of action

None (no known mechanism, as not a drug target)

03

Biological functions

None directly attributed (as a pseudogene, it does not have direct biological function or encode a protein)
04

Disease associations

Other (no direct evidence of disease involvement, but some pseudogenes may function as non-coding RNAs in cancer and gene regulation, though this is not documented for HNRNPA3P6 specifically)
05

Safety considerations

None specific (is not a therapeutic target, so no safety concerns reported)
06

Interacting drugs

None known (no drugs directly target pseudogenes such as HNRNPA3P6)
07

Biomarkers

None established (not used for patient selection or efficacy monitoring; function as biomarker has not been documented for HNRNPA3P6)

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 6 (HNRNPA3P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 6 (HNRNPA3P6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call